Abstract
Two research groups led by Dr. Bin Gao of National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, MD, USA and Dr. Keji Zhao of National Heart, Lung, and Blood Institute, National Institutes of Health, MD, USA, respectively, won the 2015 Ming K Jeang Award for excellence in Cell & Bioscience.
Editorial
We are very pleased to announce that two research groups, who each published an outstanding research article in Cell & Bioscience in 2015, have been selected to receive the Ming K Jeang Award for excellence in Cell & Bioscience. The Ming K Jeang Award for excellence in Cell & Bioscience was established in 2011 with a generous donation from the Ming K. Jeang Foundation to honor outstanding research articles published in Cell & Bioscience, the official journal of the Society of Chinese Bioscientists in America (SCBA; www.scbasociety.org). A committee of Cell & Bioscience editors, chaired by Dr. Dong-Yan Jin, considered all research articles published in the journal in 2015 to select the following two articles to receive the award [1, 2]:
Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences
Ogyi Park, Sung Hwan Ki, Mingjiang Xu, Hua Wang, Dechun Feng, Joseph Tam, Douglas Osei-Hyiaman, George Kunos and Bin Gao Cell & Bioscience 2015 5:25
Division of labor between IRF1 and IRF2 in regulating different stages of transcriptional activation in cellular antiviral activities
Gang Ren, Kairong Cui, Zhiying Zhang and Keji Zhao Cell & Bioscience 2015 5:17
Congratulations to these two groups of investigators for jobs well done!
We are looking forward to receiving contributions of outstanding research articles from the scientific community in 2016 and beyond.
Acknowledgements
I would like to thank Dr. Dong-Yan Jin and the other editors for reviewing and selecting the awardees. The opinions expressed in this editorial are the author’s personal views and do not necessarily reflect the views of his employer, the National Institutes of Health, USA.
References
- 1.Park O, Ki SH, Xu M, Wang H, Feng D, Tam J, Osei-Hyiaman D, Kunos G, Gao B. Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences. Cell Biosci. 2015;5:25. doi: 10.1186/s13578-015-0015-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ren G, Cui K, Zhang Z, Zhao K. Division of labor between IRF1 and IRF2 in regulating different stages of transcriptional activation in cellular antiviral activities. Cell Biosci. 2015;5:17. doi: 10.1186/s13578-015-0007-0. [DOI] [PMC free article] [PubMed] [Google Scholar]